在首次取卵日播放患者旅程视频片段联合标准护理:一项随机对照试验
这项单中心开放标签随机对照试验将190对夫妇随机分组,干预组在首次取卵前一日额外观看患者旅程视频。意向性分析纳入155对夫妇,结果显示视频未影响女性取卵日焦虑(STAI-State评分42.7±8.1 vs 42.1±8.5,P=0.68),但男性焦虑显著降低(35.8±6.4 vs 38.2±7.6,P=0.034),且男女不孕特异性痛苦更高。
要点
- 视频未降低女性首次取卵日焦虑(平均STAI-State评分42.7±8.1 vs 42.1±8.5,P=0.68)。
- 观看视频的男性焦虑显著低于未观看者(35.8±6.4 vs 38.2±7.6,P=0.034)。
- 观看视频的男女不孕特异性痛苦更高(女性25.8±4.9 vs 24.3±4.6,P=0.051;男性22.6±5.0 vs 20.8±4.7,P=0.023)。
核心结论
- 视频片段不影响女性首次取卵日的焦虑,但显著降低男性焦虑,且与男女更高的不孕特异性痛苦相关。
- 定性过程评估显示视频未增加知识,部分患者认为侵入性操作可视化比抽象书面信息更具冲击性。
- 干预组除一名女性外所有女性和所有男性均会向亲友推荐该视频。
研究设计与样本
- 单中心开放标签随机对照试验,计算机1:1随机分配190对异性夫妇,招募期2018—2020年共24个月。
- 干预组在首次取卵前一日额外观看患者旅程视频片段,对照组仅接受标准护理。
- 随机对照试验完成后额外招募35对夫妇进行定性过程评估。
- 155对夫妇(每组76—79对)纳入意向性分析,24个月后从电子病历提取临床和中断结局。
主要发现
- 女性取卵日焦虑平均STAI-State评分干预组42.7±8.1 vs 对照组42.1±8.5,P=0.68。
- 男性焦虑干预组35.8±6.4 vs 对照组38.2±7.6,P=0.034。
- 女性不孕特异性痛苦IDS评分干预组25.8±4.9 vs 对照组24.3±4.6,P=0.051。
- 男性不孕特异性痛苦IDS评分干预组22.6±5.0 vs 对照组20.8±4.7,P=0.023。
- 干预组和对照组在次要临床及中断结局方面无差异。
关键数值与推荐
- 定性过程评估显示观看视频未增加对取卵日流程的知识。
- 部分男女认为侵入性操作步骤的可视化比先前接受的抽象书面和口头信息更具冲击性。
- 干预组除一名女性外所有女性和所有男性均会向亲友推荐该视频。
临床怎么用
- 作者认为提供额外程序信息对诊所具有意义,因为患者推荐该视频且视频降低了男性在夫妇首次取卵日的焦虑。
- 作者提出在非母语人群及教育或识字水平较低患者中研究视频的益处可能值得关注,因其更易健康信息过载且常受益于视觉而非口头或书面信息。
局限性
- 由于干预性质无法对参与者设盲。
- 未设注意力对照组,无法将干预的合理益处与注意力效应分离,尽管教育干预研究中限制实施偏倚困难因研究人员无法设盲。
- 该随机对照试验部分在COVID-19大流行期间进行,取卵推迟及大流行本身可能影响结果,但组间差异由随机对照设计校正。
- 干预效果在荷兰语人群中观察到,在非母语及教育或识字水平较低患者中的益处有待研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can a video clip detailing the patient journey decrease women's anxiety on the day of their first oocyte retrieval? SUMMARY ANSWER: The video clip does not affect women's anxiety on the day of their first oocyte retrieval. WHAT IS KNOWN ALREADY: IVF triggers anxious reactions in women and men, with peaks of anxiety on the day of (especially the first) oocyte retrieval as shown by reliable questionnaires and biomarkers of distress. Several trials showed that videos with preparatory information reduce women's and men's anxiety for out-patient procedures. STUDY DESIGN, SIZE, DURATION: This monocentric open-label randomized controlled trial (RCT) randomized (computerized 1:1 allocation) 190 heterosexual couples about to start their first IVF cycle during a 24 months' recruitment period (2018-2020). In addition to the standard of care offered to both the intervention group and the control group, the intervention group received a video clip, the day prior to their first oocyte retrieval, detailing the patient journey on the day of oocyte retrieval. After completion of the RCT, 35 additional couples were recruited as part of a qualitative process evaluation (QPE). PARTICIPANTS/MATERIALS, SETTING, METHODS: Upon arrival at a private secondary care fertility centre in Belgium for their first oocyte retrieval, women and men independently filled out the State module of the 'State-Trait Anxiety Inventory' (STAI) and the 'Infertility-Specific Distress Scale' (IDS) and evaluated the novel intervention, if applicable. In addition, clinical and discontinuation outcomes were extracted from couples' electronic medical records 24 months later. The data of 155 couples (76-79/group) were subjected to an intention-to-treat analysis. The 35 couples taking part in the QPE filled out two questionnaires assessing knowledge and, if applicable, took part in an in-depth interview on their experience watching the video clip, immediately before their first oocyte retrieval. MAIN RESULTS AND THE ROLE OF CHANCE: The video clip did not affect women's anxiety on the day of oocyte retrieval (mean STAI-State score intervention group = 42.7 ± 8.1 vs control group = 42.1 ± 8.5, P = 0.68). Men who watched the video clip were, however, significantly less anxious than men who did not watch it (35.8 (±6.4) vs 38.2 (±7.6), P = 0.034). Surprisingly, infertility-specific distress was higher among women and men who watched the video clip, as compared to women and men who did not watch the video clip (mean Infertility-specific Distress (IDS) scale score for women, 25.8 (±4.9) vs 24.3 (±4.6), P = 0.051; men, 22.6 (±5.0) vs 20.8 (±4.7), P = 0.023). The QPE clarified that watching the video clip did not increase knowledge about what would happen but that some women and men found the visualization of invasive procedural steps more confrontational than the earlier received, abstract, written, and verbal information. All but one woman and all men in the intervention group would recommend the video clip to friends and family going through IVF. The intervention and control groups did not differ regarding secondary clinical and discontinuation outcomes. LIMITATIONS, REASONS FOR CAUTION: Due to the nature of the intervention it was not possible to blind the participants. Furthermore, we did not have an attention control group, which could have separated plausible benefits of the intervention from attentional effects, although limiting performance bias in educational intervention studies is difficult as study personnel cannot be blinded. Of note, this RCT was partially conducted during the COVID-19 pandemic; thus, postponement of the oocyte retrieval and plausible side effects of the pandemic itself might have impacted our results, but group differences are corrected by the randomized controlled design of our trial. WIDER IMPLICATIONS OF THE FINDINGS: Providing additional procedural information is interesting for clinics as patients recommended the video clip and as it decreased men's anxiety on the day of couples' first oocyte retrieval. The effect of the intervention was observed in a Dutch-speaking population, and investigating beneficial effects of the video clip in non-native speakers and patients with a lower education or literacy level may be of interest, as they are more prone to health information overload and often benefit from visual rather than verbal or written information. STUDY FUNDING/COMPETING INTEREST(S): This research was supported by the Research Council of the KU Leuven (C14/18/106; project of J.V., K.P., and E.A.F.D.) and it is an Investigator Sponsored Study for Merck N.V./S.A., an affiliate of Merck KGaA, Darmstadt, Germany. Merck N.V./S.A. had no ultimate authority nor any other role in the design, data collection, data management, data analysis, data processing, data interpretation, and on the decision to submit this study for publication. T.M.D. is vice president and Head of Global Medicine Affairs Fertility, Research and Development, Merck Healthcare KGaA, Darmstadt, Germany. He is also a visiting professor in Reproductive Medicine and Biology at KU Leuven, Belgium and an adjunct professor at the Department of Obstetrics and Gynecology at the University of Yale, New Haven, USA. Neither his corporate role nor his academic roles represent a conflict of interest with respect to the work done by him for this study. The other co-authors have no conflict of interest. TRIAL REGISTRATION NUMBER: This trial is registered at clinicaltrials.gov as NCT03717805. TRIAL REGISTRATION DATE: 10 October 2018. DATE OF FIRST PATIENT’S ENROLMENT: 29 October 2018.
引用
- Dias L, De Loecker P, Willems S, et al. A video clip detailing the patient journey on the day of oocyte retrieval in addition to the standard of care: a randomized controlled trial. Hum Reprod. 2025. PMID: 40056004. doi:10.1093/humrep/deaf033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。